IL‐6 has also been identified to play an important role in the inflammatory pathway of rheumatoid arthritis in humans and has led to the development of targeted anti‐IL‐6 therapy (Akioka, 2019). The gene discussed is IL6; the disease is rheumatoid arthritis.